JS
Josh Schimmer Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
35
Avg Return
Past Year
Past Year
23%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
94.4%
Neutral
5.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Industrials
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Care Facilities
Industrials
Specialty Industrial Machinery
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $150 |
816%
upside
| 2 | -49% |
0
%
| 2 Dec ‘25 2 days ago |
|
|
|
Overweight
Initiated
| $25 |
192%
upside
| 1 | +58% |
0
%
| 14 Nov ‘25 20 days ago |
|
|
|
Overweight
Maintained
| $200 |
113%
upside
| 1 | +24% |
0
%
| 6 Nov ‘25 28 days ago |
|
|
|
Overweight
Maintained
| $95 |
32%
upside
| 1 | +1% |
0
%
| 5 Nov ‘25 29 days ago |
|
|
|
Overweight
Maintained
| $30 |
1,054%
upside
| 2 | +33% |
0
%
| 31 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $110 |
47%
upside
| 4 | +21% |
0
%
| 30 Oct ‘25 1 month ago |
|
|
|
Overweight
Initiated
| $135 |
26%
upside
| 1 | +26% |
0
%
| 15 Oct ‘25 1 month ago |
|
|
|
Overweight
Initiated
| $10 |
352%
upside
| 1 | +91% |
0
%
| 6 Oct ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $65 |
9%
downside
| 1 | +74% |
0
%
| 22 Sep ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $75 |
67%
upside
| 2 | +42% |
0
%
| 8 Sep ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| – | – | 1 | +32% |
0
%
| 8 Sep ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $25 |
4%
downside
| 3 | +34% |
0
%
| 5 Sep ‘25 3 months ago |
|
|
|
Overweight
Maintained
| $8 |
134%
upside
| 3 | -24% |
0
%
| 8 Aug ‘25 3 months ago |
|
|
|
Overweight
Initiated
| $25 |
84%
upside
| 1 | +148% |
0
%
| 1 Jul ‘25 5 months ago |
|
|
|
In-Line
Downgraded
| $6 |
7%
upside
| 2 | +6.2% |
0
%
| 23 Jun ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $280 |
35%
upside
| 3 | +15% |
0
%
| 2 May ‘25 7 months ago |
|
|
|
Overweight
Reiterated
| $50 |
304%
upside
| 2 | +20% |
0
%
| 1 Apr ‘25 8 months ago |
|
|
|
Overweight
Maintained
| $20 |
443%
upside
| 1 | -5.9% |
0
%
| 25 Mar ‘25 8 months ago |
|
|
|
Overweight
Reiterated
| $215 |
3%
downside
| 1 | +26% |
0
%
| 20 Feb ‘25 9 months ago |
|
|
|
In-Line
Downgraded
| $5 |
118%
upside
| 1 | – |
–
| 20 Dec ‘24 11 months ago |
|
|
|
Overweight
Reiterated
| $25 | – | 1 | +92% |
0
%
| 11 Dec ‘24 11 months ago |
|
|
|
Overweight
Reiterated
| – | – | 1 | +39% |
0
%
| 11 Dec ‘24 11 months ago |
|